IT, Technology & Devices CSR News

Are you Sitting Yourself to an Early Death?

Blog

Deborah Hecker

Vice President, Sustainability and Corporate Social Responsibility

Do you start your day with a run or workout? Good start, but it’s not enough. If you work in an office, you’re sitting yourself to death.

Vigilant Global’s Successful Journey Through Quebec’s Countryside with the Enbridge Ride to Conquer Cancer

Coming together for a cause
Blog

With the help of Friends, families and Sponsors (Bloomberg, Davies Ward & Selerity) Vigilant Global’s Vigi4Cure team completed their fourth journey to Quebec City on July 11-12 with the Enbridge Ride to Conquer Cancer. A total of 1,347 participants raised a total of $4.9 million for the Segal Cancer Center at the Jewish General Hospital. 

Read more about the journey here.

Picture Your Life. Picture How Quickly It Can Change.

By: Michelle Kuckelman
Blog

Picture this. You’re driving in your neighborhood. Your phone beeps. You take your eyes off the road for just a second. What happens next…could be life-changing.

It’s hard to envision a moment like that until you experience it. And we don’t want that to happen. So we’re bringing it to life—virtually.

Wearables in the Workplace: 3 Reasons to Test in Manufacturing

by Heather Franzese & Tom Rausch of Good World Solutions
Summary: 

Good World Solutions is a partner of Cisco CSR. Cisco sponsors The Huffington Post's ImpactX section.

Blog

Good World Solutions is a partner of Cisco CSR. Cisco sponsors The Huffington Post's ImpactX section.

The Small Device We Take for Granted That Can Save Lives in Impoverished Areas

by Abi Weaver, Global Technology Project Director, American Red Cross
Summary: 

The American Red Cross is a partner of Cisco CSR. Cisco sponsors The Huffington Post's ImpactX section.

Blog

The American Red Cross is a partner of Cisco CSR. Cisco sponsors The Huffington Post's ImpactX section.

See you at CleanMed 2015?

By Carol Baroudi
Blog

Not all conferences are created equal, and CleanMed is one of my very favorites. Some of the founding members of Practice Greenhealth and Healthcare without Harm, the conference organizers, were early adopters of environmentally responsible IT asset disposition (ITAD).

Cox Enterprises Invests In Digital Health Company Rimidi

Funding will allow company to expand to additional markets
Press Release

ATLANTA, April 29, 2015 /3BL Media/ – Cox Enterprises announced today an investment in Atlanta-based Rimidi, a digital health company focused on diabetes and other chronic conditions. This marks a major milestone for the company, paving the way for Rimidi’s expansion into additional markets and collaborative opportunities.

Beyond GSK: An insider look at STEMAccelerator

STEMAccelerator is helping kids prepare for exciting STEM careers and is supported through GSK's $1 million grant.
Multimedia with summary

The new Beyond GSK segment is centered on STEM (science, technology, engineering, and math) education and GSK’s one million dollar commitment to NC New Schools’ brand new initiative called STEMAccelerator. In this episode, you will meet Cyclops, a robot made from nuts, bolts, sensors and switches. Cyclops is one way that high school students in North Carolina are being inspired by science, technology, engineering, and math (STEM). 

2015 GBCHealth-GHC Business Action on Health Awards | Call For Applications

Press Release

April 29, 2015 /3BL Media/ - GBCHealth and Global Health Council (GHC) are pleased to announce a call for applications for the 2015 GBCHealth-GHC Business Action on Health Awards. These awards highlight the important and innovative contributions of the corporate sector to improving global health outcomes.

FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart

The 50cc heart is the smaller version of the 70cc SynCardia Heart, which is FDA, Health Canada and CE mark approved. It is designed for implantation in most women, smaller men and many adolescents with end-stage biventricular heart failure.
Press Release

March 31, 2015 /3BL Media/ - SynCardia Systems, Inc. has received FDA approval to conduct an Investigational Device Exemption (IDE) clinical study on the effective use of its 50cc SynCardia temporary Total Artificial Heart.

Pages

Subscribe to IT, Technology & Devices